Morgan Stanley analyst Erin Wright raised the firm’s price target on Cardinal Health (CAH) to $245 from $224 and keeps an Overweight rating on the shares. The “Golden Era” of healthcare distribution continues, argues the analyst, who still sees scope for group multiple expansion in a “robust backdrop” and also cites the relative policy insulation of the group.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target raised to $233 from $225 at TD Cowen
- Wells says ‘Great Healthcare Plan’ lacks new onerous proposals
- Cardinal Health price target raised to $240 from $230 at BofA
- Cardinal Health price target raised to $250 from $232 at Baird
- Cardinal Health price target raised to $240 from $230 at Leerink